Apr 1 |
Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development
|
Mar 18 |
15 Best Anti-Aging Foods for Youthful Skin
|
Mar 18 |
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium
|
Mar 11 |
RG6501 (OpRegen®) Preclinical Engraftment Results to Be Presented at 2024 Association for Research in Vision and Ophthalmology Meeting
|
Mar 8 |
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q4 2023 Earnings Call Transcript
|
Mar 8 |
Lineage Cell Therapeutics Inc. Reports Q4 and Full Year 2023 Financial Results
|
Mar 8 |
Lineage Cell Therapeutics, Inc. (LCTX) Q4 2023 Earnings Call Transcript
|
Mar 7 |
Lineage Cell Therapeutics GAAP EPS of -$0.03 in-line, revenue of $2.1M misses by $0.74M
|
Mar 7 |
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
|
Mar 7 |
Earnings Scheduled For March 7, 2024
|